Ariel Katz
Forbes Councils Member|
COUNCIL POST
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author.
Membership (fee-based)545 viewsFeb 21, 2024
Top Five Imperatives For Healthcare And Pharmaceutical Leaders In 2024
Patients expect the same seamless experience in their healthcare journey as with e-commerce and demand the capability to do things on their own terms.
498 viewsDec 21, 2023
Three Key Imperatives Needed To Advance AI’s Use In Clinical Trials
Despite major investments, there are a few roadblocks when executing an AI strategy.
4,525 viewsSep 19, 2023
10 Ways AI Is Advancing Healthcare
Though there are challenges to be understood and overcome, AI is significantly improving the healthcare landscape.
618 viewsJul 26, 2023
Forcing The Hand Of Health Equity: Changing The Future Of Clinical Trial Recruitment (Part 2)
While ensuring diversity throughout the drug lifecycle—from clinical trial design to commercial launches—is the goal, the reality of achieving it is complex.
696 viewsJun 9, 2023
Health Equity And Why The Government Should Intervene: Part 1
Legislation is necessary to address these issues and ensure that diverse populations are adequately represented in medical research.